Touyun Biotech Group Limited's (HKG:1332) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Touyun Biotech Group Limited (HKG:1332) shares have retraced a considerable 28% in the last month, reversing a fair amount of their solid recent performance. For any long-term shareholders, the las
Simply Wall StApr 22 18:43 ET
Touyun Biotech (01332) released annual results, losses attributable to shareholders of 269 million yuan, an increase of 35.78% year-on-year
According to the Zhitong Finance App, Touyun Biotech (01332) announced its annual results for the year ended December 31, 2023. The group achieved gross profit of HK$55.99 million during the period, a year-on-year decrease of 56.13%; shareholders' losses of 269 million yuan, an increase of 35.78% over the previous year; and a basic loss of 9.58 HK cents per share. According to the announcement, for the year ended 31 December 2023, the Group obtained revenue of approximately HK$198.6 million (2022: HK$315.8 million), a decrease of approximately 37.1% compared to last year. The decrease in turnover was mainly due to a decrease in sales orders for packaged products.
Zhitong FinanceMar 28 12:42 ET
TOUYUN BIOTECH: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Futu NewsMar 28 09:59 ET · Announcements
Touyun Biotech (01332.HK) held a board meeting on March 28 to approve publication of annual results
Gelonghui, March 14, 丨 Touyun Biotech (01332.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to approve (among other things) the publication of the annual results announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the payment of a final dividend.
Gelonghui FinanceMar 14 04:50 ET
Touyun Biotech [01332] now reports HK$0.241, an increase of 14.22%
As of 15:02, Touyun Biotech [01332] reported HK$0.241, up HK$0.03 or 14.22% from yesterday's closing price, with a turnover of HK$40,700, today's high of HK$0.24 and the lowest price of HK$0.211. Based on yesterday's closing price, the 10-day average price was HK$0.17, and the 50-day average price was HK$0.26. The current price-earnings ratio was -2.99 times, and the 14-day strength and weakness index reported 54.97.
金吾財訊Feb 7 02:02 ET
Some Confidence Is Lacking In Touyun Biotech Group Limited (HKG:1332) As Shares Slide 49%
The Touyun Biotech Group Limited (HKG:1332) share price has fared very poorly over the last month, falling by a substantial 49%. The drop over the last 30 days has capped off a tough year for share
Simply Wall StJan 2 17:49 ET
TOUYUN BIOTECH: INTERIM REPORT 2023
Futu NewsSep 28, 2023 05:29 ET · Announcements
Some Confidence Is Lacking In Touyun Biotech Group Limited (HKG:1332) As Shares Slide 26%
Touyun Biotech Group Limited (HKG:1332) shareholders won't be pleased to see that the share price has had a very rough month, dropping 26% and undoing the prior period's positive performance. The d
Simply Wall StSep 12, 2023 18:14 ET
Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it seems the smart m
Simply Wall StSep 7, 2023 18:08 ET
Touyun Biotech (01332) Announces Interim Results, Shareholders' Share of Loss of HK$83.951 million narrowed 4.67% year-on-year
Touyun Biotech (01332) announced its interim results for the six months ended June 30, 2023. The group collected during the period...
Zhitong FinanceAug 25, 2023 10:08 ET
TOUYUN BIOTECH: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Futu NewsAug 25, 2023 10:02 ET · Announcements
Tuyun Biotech (01332.HK) will hold a board meeting on August 25 to approve the interim results
On August 11, GLONGWI | TOYUNBIO (01332.HK) announced that the company will hold a board meeting on August 25, 2023 to approve the publication of the company and its subsidiaries's interim results announcements for the six months ended June 30, 2023, and consider the payment of interim dividends.
Gelonghui FinanceAug 11, 2023 06:26 ET
TOUYUN BIOTECH: DATE OF BOARD MEETING
Futu NewsAug 11, 2023 06:24 ET · Announcements
Touyun Biotech: 2022 Annual Report
moomoo NewsApr 27, 2023 04:43 ET · Announcements
Touyun Biotech: Annual Results Announcement for the Year Ended December 31, 2022
moomoo NewsMar 27, 2023 10:29 ET · Announcements
The 64% Return This Week Takes Touyun Biotech Group's (HKG:1332) Shareholders Three-year Gains to 224%
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a really great company, you can more than double your money. To wit, the Touyun B
Simply Wall StJan 5, 2023 19:55 ET
Cloud-penetrating organisms: interim report 2022
富途資訊Sep 21, 2022 05:40 ET · Announcements
Is Touyun Biotech Group (HKG:1332) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when
Simply Wall StSep 13, 2022 19:45 ET
Cloud Biology: interim results for the six months ended June 30, 2022
富途資訊Aug 26, 2022 08:02 ET · Announcements
Cloud-penetrating organisms: annual report 2021
富途資訊Apr 28, 2022 08:14 ET · Announcements
No Data
No Data